Literature DB >> 14604461

Hepatocyte hollow-fibre bioreactors: design, set-up, validation and applications.

Corinne Planchamp1, Thanh L Vu, Joachim M Mayer, Marianne Reist, Bernard Testa.   

Abstract

Hepatocytes carry out many vital biological functions, such as synthetic and catabolic reactions, detoxification and excretion. Due to their ability to restore a tissue-like environment, hollow-fibre bioreactors (HFBs) show great potential among the different systems used to culture hepatocytes. Several designs of HFBs have been proposed in which hepatocytes or hepatocyte-derived cell lines can be cultured in suspensions or on a solid support. Currently the major use of hepatocyte HFBs is as bioartificial livers to sustain patients suffering from acute liver failure, but they can also be used to synthesize cell products and as cellular models for drug metabolism and transport studies. Here, we present an overview of the set-up of hepatocyte HFBs and aim to provide potential users with the basic knowledge necessary to develop their own system. First, general information on HFBs is given, including basic principles, transport phenomena, designs and cell culture conditions. The importance of the tests necessary to assess the performance of the HFBs, i.e. the viability and functionality of hepatocytes, is underlined. Special attention is paid to drug metabolism studies and to adequate analytical methods. Finally, the potential uses of hepatocyte HFBs are described.

Entities:  

Mesh:

Year:  2003        PMID: 14604461     DOI: 10.1211/0022357021963

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  4 in total

1.  Future of bioartificial liver support.

Authors:  Robert Afm Chamuleau
Journal:  World J Gastrointest Surg       Date:  2009-11-30

Review 2.  Bioreactor technologies to support liver function in vitro.

Authors:  Mohammad R Ebrahimkhani; Jaclyn A Shepard Neiman; Micha Sam B Raredon; David J Hughes; Linda G Griffith
Journal:  Adv Drug Deliv Rev       Date:  2014-03-05       Impact factor: 15.470

3.  Modifying three-dimensional scaffolds from novel nanocomposite materials using dissolvable porogen particles for use in liver tissue engineering.

Authors:  Hussamuddin Adwan; Barry Fuller; Clare Seldon; Brian Davidson; Alexander Seifalian
Journal:  J Biomater Appl       Date:  2012-04-24       Impact factor: 2.646

Review 4.  Comprehensive Evaluation of Organotypic and Microphysiological Liver Models for Prediction of Drug-Induced Liver Injury.

Authors:  Yitian Zhou; Joanne X Shen; Volker M Lauschke
Journal:  Front Pharmacol       Date:  2019-09-24       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.